VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,927,000 | +29.8% | 384,141 | -11.1% | 0.05% | +6.4% |
| Q1 2018 | $6,879,000 | -20.3% | 432,093 | +4.1% | 0.05% | -17.5% |
| Q4 2017 | $8,628,000 | +50.2% | 415,202 | +3.5% | 0.06% | +39.0% |
| Q3 2017 | $5,746,000 | -17.2% | 401,002 | 0.0% | 0.04% | -22.6% |
| Q2 2017 | $6,938,000 | +2074.9% | 401,002 | +1285.5% | 0.05% | +2550.0% |
| Q1 2017 | $319,000 | -48.2% | 28,942 | +737.4% | 0.00% | -75.0% |
| Q3 2015 | $616,000 | -59.6% | 3,456 | -49.6% | 0.01% | -52.9% |
| Q2 2015 | $1,524,000 | +89.3% | 6,859 | +69.3% | 0.02% | +88.9% |
| Q1 2015 | $805,000 | +44.8% | 4,052 | +4.4% | 0.01% | +28.6% |
| Q4 2014 | $556,000 | -3.3% | 3,883 | -11.4% | 0.01% | 0.0% |
| Q3 2014 | $575,000 | +27.5% | 4,381 | +22.6% | 0.01% | -12.5% |
| Q2 2014 | $451,000 | +0.7% | 3,573 | +5.1% | 0.01% | 0.0% |
| Q1 2014 | $448,000 | +62.9% | 3,400 | +45.2% | 0.01% | +33.3% |
| Q4 2013 | $275,000 | 0.0% | 2,341 | -11.3% | 0.01% | 0.0% |
| Q3 2013 | $275,000 | +21.1% | 2,639 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $227,000 | – | 2,639 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |